NCT06200103 - Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer | Biotech Hunter

Enrollment

236

Participants

Timeline

Start Date

May 3, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions

Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8

Interventions

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

PROCEDURE

Bone Scan

Undergo bone scan

OTHER

Clinical Observation

Undergo active monitoring

PROCEDURE

Computed Tomography

Undergo SPECT/CT or PET/CT

OTHER

Gallium Ga 68 Gozetotide

Given IV

DRUG

Lutetium Lu 177 Vipivotide Tetraxetan

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Single Photon Emission Computed Tomography

Undergo SPECT/CT

Trial Locations (1)

RECRUITING

Mayo Clinic in Rochester, Rochester